April 25, 2026 02:46 am (IST)
Follow us:
Zydus Cadila receives USFDA approval to market Carboplatin Injection
Ahmedabad, Apr 1 (IBNS) Zydus Cadila, a fully integrated, global healthcare provider, announced on Friday that it has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Vee Technologies’ engineering division delivers 3,000th fire truck design for the US
Fri, Apr 24 2026
Nissan Motor India, Avis India announce partnership for leasing and subscription-based solutions
Fri, Apr 24 2026
Infosys shares extend losses to 6% post Q4 results
Fri, Apr 24 2026
Meta to cut 8,000 jobs: Reports
Fri, Apr 24 2026
As Tim Cook steps down, Sundar Pichai’s reaction grabs attention
Wed, Apr 22 2026